Pharmacokinetics and tissue elimination of flunixin in veal calves

Authors

  • G. W. Smith Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607
  • P. D. Brinson Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607
  • R. Gehring Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66502
  • R. E. Baynes Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607
  • L. W. Kissell Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607
  • L. A. Tell Department of Medicine and Epidemiology, University of California-Davis, Davis, CA 95616

DOI:

https://doi.org/10.21423/aabppro20143729

Keywords:

veal calves, flunixin, extra-label drug use, contamination, pharmacokinetics

Abstract

Currently flunixin is one of the leading violative drug residue found in veal calves. Although it is approved for use in adult cattle, there is not a specific approval for use in calves that are to be processed for veal. However the drug is often used in an extralabel manner as supportive therapy associated with calf diarrhea or pneumonia. Unfortunately pharmacokinetic data regarding the use of flunixin in young calves is not available. Therefore the primary objective of this study was to examine the pharmacokinetics and tissue elimination of flunixin following administration to veal calves.

Downloads

Published

2014-09-18

Issue

Section

Research Summaries 3

Most read articles by the same author(s)

<< < 1 2